To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

July 5, 2022

GBM Treatment Info Presented by Dr. Lustgarten

On May 19th, 2022, The End Brain Cancer Initiative held our GBM "Know All Your Treatment Options" Educational, Advocacy & Outreach event. We had amazing speakers and among them was Dr. Leo Lustgarten, US Director for Neuro-oncology and Global Clinical Lead at Novocure. Dr. Lustgarten shared some incredibly valuable information that we would like to share with you in case you missed it! 

Dr. Lustgarten and his work

Dr. Leonardo Lustgarten, MD, is originally from Caracas, Venezuela. Dr. Lustgarten completed his residency in Venezuela, and then trained further as a neurosurgeon at the Radcliffe Infirmary at University of Oxford, UK and also as a visiting academic at the Neurological Institute of New York at Columbia Presbyterian. 

For over 20 years in Venezuela, as a neurosurgeon and radiosurgeon, Dr. Lustgarten performed surgeries on brain tumors, both in adult and pediatric patients, as well as stereotactic procedures. He is now the US Director for Neuro-oncology and Global Clinical Lead for glioblastoma trials at Novocure.

For additional questions please contact:

Treatment options logo

If you missed our full "Know All Your Treatment Options" event on May 19th, we have linked the entire video below.

Supporter logos


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram